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Abstract. To determine the risk for Chagas disease (American trypanosomiasis) in the United States, the characteristics
that make the triatomine vector effective and the areas most at risk for transmission were delineated. In addition, the
status of Chagas disease awareness among physicians in areas with a potential risk for the disease was determined. A
geographical information system (GIS) was used to analyze three triatomine species within the United States known to
harbor Trypanosoma cruzi and that exhibit qualities of domesticity. An analysis of the minimum temperature thresh-
old for increased triatomine activity delineates the current population at increased risk, and by incorporating temper-
ature predictions for 2030, the population at risk under a future climate scenario was also delineated. Considering both
environmental and social factors, a vignette-based physician survey, based on the results of the GIS analysis, was used
to gauge the level of awareness of Chagas disease within the delineated higher risk range. The current area at increased
risk for Chagas disease includes much of the southern United States, and the higher risk range is expected to expand
into the central United States based upon the 1°C (1.8°F) increase in temperature predicted by the Intergovernmental
Panel on Climate Change (IPCC) by the year 2030. Survey results indicate a limited consideration of Chagas disease
during differential diagnosis, illustrating that the low number of Chagas disease cases discovered in the United States
may be attributable to a lack of disease awareness as opposed to a lack of disease threat. This study combines GIS and
survey analyses to evaluate the role that temperature variability and disease awareness among physicians play in the
potential emergence of Chagas disease in the United States. This approach indicates that there is a potential for Chagas
disease to emerge in the United States.
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Introduction
Chagas disease (also known as American try-
panosomiasis) is endemic in Central and South
America, and the disease agent, Trypanosoma cruzi,
primarily spreads to humans as a result of blood
feeding by the triatomine vector, also known as the
“kissing bug” (CDC, 2006). In the United States,
triatomines have been found in proximity to
humans, indicating an opportunity for the emer-
gence of Chagas disease. There have only been six
autochthonous (locally acquired) cases diagnosed in
the United States since 1955 (Woody and Woody,
1955; Anonymous, 1956; Betz et al., 1984; Schiffler
et al., 1984; Navin et al., 1985; Ochs et al., 1996;
Herwaldt et al., 2000; Dorn et al., 2007). However,
given the increase in the domestic presence of the
vector in close proximity to humans, the possibility
of future temperature increases, and changing habi-
tation to areas within the vector’s range, the poten-
tial exists for the disease to become established in
the United States.
Corresponding author:
Korine N. Kolivras
Department of Geography
Virginia Polytechnic Institute and State University (Virginia Tech)
115 Major Williams Hall Blacksburg, VA 24061, USA
Tel. +1 540 231 5514; Fax +1 540 231 2089
E-mail: korine@vt.edu
Geospatial Health 2(2), 2008, pp. 227-239
R. Click Lambert et al. - Geospatial Health 2(2), 2008, pp. 227-239228
The potential for the emergence of Chagas dis-
ease in the United States presents an example of
the way in which disparate factors can affect dis-
ease dispersion. The triatomine’s activity level is
affected by temperature, and physicians are often
the first to diagnose and respond to an emerging
disease threat. Additionally, the literature indi-
cates that cases beyond the six recorded so far are
likely to have gone undiagnosed, indicating a need
to evaluate physician awareness (Kirchhoff et al.,
1987; Kirchhoff, 1993; Holbert et al., 1995; Leiby
et al., 2000, 2002; Zayas et al., 2001; Kirchhoff et
al., 2006; Dorn et al., 2007). Through the use of
geographical information system (GIS) and survey
analyses, this study examines the role that climate
conditions (temperature) and disease awareness
among physicians can play in the potential emer-
gence of Chagas disease in the United States.  
Increased globalization and migration have con-
tributed to the emergence of a number of infec-
tious diseases in recent decades. Specifically, in the
medical field, global travel, increased urbaniza-
tion, and suburbanization have played a role in
the emergence of the severe acute respiratory syn-
drome (SARS), dengue fever, and Lyme disease
(Haggett, 1994; Cooke and Shapiro, 2003).
Additionally, there are indications that climate
change particularly contributes to the spread of
parasitic diseases into new locations. For example,
the consequences of climate variability and change
have been pointed out for schistosomiasis in the
north of China (Yang et al., 2006), and are
already evident in the case of malaria, which has
become established at higher elevations in Africa
in recent years (Epstein et al., 1998).
Given that physicians may be the first to recog-
nize a newly emerged disease as cases present
themselves in a hospital or in a doctor’s office
(Cooke and Shapiro, 2003), gauging Chagas dis-
ease awareness might provide a useful measure of
the potential for Chagas to emerge in the United
States. We specifically concentrated our efforts on
the area deemed at highest risk for Chagas trans-
mission based on temperature. While studies have
examined the potential for Chagas disease emer-
gence in specific regions of the United States
(Peterson et al., 2002; Beard et al., 2003), no study
has evaluated the potential across the country as a
whole by examining both climatic factors and
physician awareness. Our approach aims to do this
and methodologically, it combines GIS and survey
analyses as a way to more completely evaluate the
potential for disease emergence. Two important
factors support the potential emergence of Chagas
disease in the United States and guide our research
objectives: the vector is established and, with cli-
mate variability and change, it may increase con-
tact with humans (Lent and Wygodzinsky, 1979);
and immigrants carrying T. cruzi have migrated to
the United States from endemic areas (Kirchhoff et
al., 1987).
This study is built on the theoretical frameworks
of landscape epidemiology and disease ecology
within medical geography. The three main factors
of disease ecology include the environment,
human behaviour, and population characteristics
(Meade and Earickson, 2005). Complimentary to
all three factors of the disease ecology approach is
landscape epidemiology, which defines a natural
disease nidus as the locale where a disease main-
tains continued circulation (Meade and Earickson,
2005). With these frameworks, we have aimed to
bridge the gap between the triatomine’s biogeo-
graphical range and awareness of the disease
among physicians. 
Our specific objectives were: 
(i) to delineate the areas that are at higher risk
for Chagas disease transmission in the United
States due to the temperature-induced increase
in activity of three triatomine species that
exhibit qualities of domesticity; and 
(ii) to determine the level of Chagas disease
awareness among physicians in regions
defined as being at higher risk for disease
transmission.
Figure 1 serves as a template for the research pre-
sented here and is based upon the frameworks
described above.
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Background
Triatomine biogeography
The range of the triatomine in the United States
covers twenty-six states and Triatoma sanguisuga,
T. lecticularia, and T. protracta, with the largest
ranges in the country (Usinger, 1944; Lent and
Wygodzinsky, 1979), have been reported in and
around human habitations (Sjogren and Ryckman,
1966; Lent and Wygodzinsky, 1979; Navin et al.,
1985; Herwaldt et al., 2000; Beard et al., 2003).
Temperature, rate of defecation, prevalence of vec-
tor infectivity, and degree of domesticity play impor-
tant roles in Chagas disease transmission. Regarding
temperature, the minimum threshold for T. cruzi
transmission is estimated to be 18°C (64°F) and
higher temperatures reportedly increase pathogen
development in the triatomine; however, tempera-
tures greater than 38°C (100°F) become lethal to the
pathogen (IPCC, 2001). Increased triatomine move-
ment in warmer temperatures may result in tri-
atomines entering the home, thus creating an oppor-
tunity for human contact with the disease vector.
The risk maps created in this study incorporate bio-
geographical and climatological factors to depict the
current and predicted higher risk range for Chagas
disease in the United States.  
In the context of disease ecology, investigating
changes in a vector’s range and habitat can gauge the
vector’s proximity to humans and quantify disease
risk. Wood (1938) described the northward range
expansion of T. protracta in California, but since
that time, research on the triatomine’s range has
been limited in the United States with the exception
of modeling the species’ range in parts of Texas
(Peterson et al., 2002; Beard et al., 2003). Modeling
efforts have mapped the triatomine range in much of
Latin America (Abad-Franch et al., 2001; Costa et
al., 2002; Peterson et al., 2002; Guzman-Tapia et al.,
2005; López-Cárdenas et al., 2005; Bustamante et
al., 2007). In particular, Peterson et al. (2002)
applied the genetic algorithm for rule-set prediction
(GARP) model to the T. gerstaeckeri species’ range in
Mexico to evaluate the environmental characteristics
under which the disease agent and vector thrive.
Similarly, a regional analysis in Guatemala utilized
environmental factors and data from field collections
to determine the Chagas disease vector’s primary
habitat range (Bustamante et al., 2007). The broad-
scale study presented here fills a gap in research on
the potential for Chagas disease emergence in the
United States by using a GIS to analyze the current
and potential triatomine range within the country.
A significant component of Chagas disease trans-
mission is the prevalence of infection in local vector
Fig. 1. Schematic defining variables for Chagas disease risk in the United States. Topics of focus in this study are domesticity
and its components, T. cruzi infection, increased flight activity, and physician awareness.
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populations (Usinger, 1944; Kagan et al., 1966).
Although the studies are somewhat dated, examina-
tions of T. protracta and T. sanguisuga samples in
the United States reveal a T. cruzi infection rate of
20% (Usinger, 1944) and 6% (Kagan et al., 1966),
respectively. Another important consideration is the
efficiency with which the triatomine transmits the
trypanosome. If the bug defecates while consuming
a blood meal, or shortly thereafter, the chances of
disease transmission via the bite wound are greater
(Kagan et al., 1966). Delayed defecation by the tri-
atomine species in the United States limits the inci-
dence of disease transmission during feeding (Kagan
et al., 1966; Lent and Wygodzinsky, 1979).
However, the risk of disease transmission to humans
via feces may be possible through contaminated
food or the mucous membranes if hygienic practices
are not followed (CDC, 2006).
When a vector bites a human, it illustrates the
domesticity of some triatomine species. Despite the
generally sylvatic nature of the triatomine species in
the United States (Kagan et al., 1966; Ryckman,
1984; Herwaldt et al., 2000; Beard et al., 2003),
and a lack of a suitable habitat in most homes with-
in the country (Zeledón, 1974), studies throughout
the Americas and within the United States report
numerous cases of sylvatic species biting humans
when an opportunity is present. Triatomines can
enter a dwelling through an unscreened open win-
dow, which may be exacerbated by an attraction to
lights that increases the triatomine’s lure to the
domestic dwelling (Usinger, 1944; Sjogren and
Ryckman, 1966; Wood and Wood, 1967; Lent and
Wygodzinsky, 1979; Monroy et al., 2003; Vazquez-
Prokopec et al., 2004, 2006). Upon entering a
home, triatomines often go undetected because they
generally feed at night and are nocturnal by nature
(Lent and Wygodzinsky, 1979; Schofield, 1979;
Navin et al., 1985; Herwaldt et al., 2000).  
Chagas disease awareness in the United States
While an understanding of the vector’s range is
important for disease control, ultimately it is physi-
cians’ awareness of a disease that is crucial for detect-
ing its emergence. We combined the GIS analysis with
a physician survey to have a more complete under-
standing of emergence potential. The diagnosis of
only six human autochthonous cases in the United
States roughly corresponds to periods in which there
was a considerable increase in Chagas disease
research and publication (Coutinho, 1999). This rela-
tionship suggests that the perceived low risk current-
ly associated with Chagas disease in the United States
is more likely due to a lack of awareness than it is a
lack of actual threat. Chagas disease is not always
considered as a diagnosis; physicians state that the
symptoms presented in the acute stage are often mis-
diagnosed, and that the differential diagnosis does
not consider Chagas disease unless there is a strong
indication (Holbert et al., 1995). Diagnosis can be
further complicated if the vector’s bite is not recog-
nized as a triatomine bite; the bite is reportedly pain-
less and often misdiagnosed as a bite from another
arthropod or a spider (Vetter, 2001). Reports such as
these indicate a need to investigate awareness of the
disease among physicians in the United States. If
physicians and the public are not aware of the poten-
tial disease threat, the possibility for misdiagnosis is
greater and cases will go undiagnosed. 
Additionally, physician awareness of the various
transmission routes is an important component in
diagnosis. In particular, Kirchhoff et al. (2006)
found that even when four recipients of infected
blood demonstrated acute symptoms of Chagas dis-
ease, the physicians failed to make the diagnosis.
Consequently, the oversight was attributed to mild
symptoms and the physicians’ lack of awareness
with respect to Chagas disease transmission through
blood transfusion (Kirchhoff et al., 2006). The
blood supply in the United States is vulnerable to
T. cruzi contamination due to an increasing Latin
American population emigrating from countries
where Chagas disease is endemic (Kirchhoff et al.,
1987, 2006; Kirchhoff, 1993; Leiby et al., 2002;
Beard et al., 2003), even though screening of blood
for Chagas disease will begin soon in the United
States (CDC, 2006; Lee, 2006). 
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Materials and methods
Delineating the range of increased triatomine activity
The data used to delineate the range of increased
triatomine activity and the area at highest risk of
disease emergence include information regarding
T. protracta activity threshold levels from the ento-
mological literature, minimum temperature data,
and census data for the United States. Sjogren and
Ryckman (1966) outlined thresholds for increased
triatomine activity, which are utilized in this study
to delineate the range where the triatomine is most
active and therefore creates a higher risk for the
emergence of Chagas disease. The minimum thresh-
old for increased triatomine activity is 19°C (67°F)
(Sjogren and Ryckman, 1966). 
Gridded average (1971-2000) minimum tempera-
ture data, based on the parameter-elevation regres-
sions on independent slopes model (PRISM) (Spatial
Climate Analysis Service, 2006), were acquired for
the months of June, July, and August based upon
accounts of increased triatomine activity in warmer
temperatures, and the tendency for those months to
be the hottest of the year in the United States
(Sjogren and Ryckman, 1966; Wood and Wood,
1967). The 800-meter resolution temperature
dataset is at an appropriate scale given the broad,
country-wide scope of the project. Other climate
variables, specifically humidity, wind speed, and
precipitation, were considered but not included in
the study given that Sjogren and Ryckman (1966)
found that they had no relationship on the flight of
T. protracta. The potential future range of increased
triatomine activity is examined based upon the pre-
diction of a 1°C (1.8°F) temperature increase by
2030 (IPCC, 2001). The use of this predicted tem-
perature increase is based upon a report by the
Intergovernmental Panel on Climate Change (IPCC)
(2001) that is derived from expert collaborations
and the assimilation of numerous climate models.
While the temperature increase may vary locally, the
predicted global mean average temperature increase
is used for the purposes of this broad-scale study. 
In order to calculate the population at risk under
current and warmer climate conditions, we acquired
1-kilometer raster grids depicting census data for
the continental United States from the
Socioeconomic Data and Applications Center
(SEDAC, 2007). To depict the proximity of the
reported triatomine samples and the six autochtho-
nous cases to the densely populated areas within the
United States, a gridded nightlights layer was
obtained from NOAA’s Defense Meteorological
Satellite Program (NOAA-NGDC, 2007). 
The minimum temperature data values for the
defined months were entered into a GIS and reclas-
sified based on the triatomine activity threshold
information. All values >19°C (67°F) were assigned
a value of 1, and all other values were assigned a
value of 0. Next, we employed a raster-to-polygon
conversion for each reclassified layer representing
the months of June, July, and August. The same
process of reclassification and conversion was then
applied using the predicted 1°C (1.8°F) increase in
temperature so as to illustrate the potential tri-
atomine range for each month under warmer cli-
mate conditions. 
Finally, we incorporated the SEDAC population
density data into the GIS using an overlay analysis.
The spatial analyst zonal statistics tool in ArcGIS
(ESRI, 2005) was utilized to establish the popula-
tion at higher risk due to increased triatomine activ-
ity. By incorporating the June, July, and August
polygons for 2000 and 2030 into spatial analyst as
individual datasets, we established the population at
higher risk of Chagas disease transmission for both
time periods and each month. To analyze the area
contained within the higher risk range for 2000 and
2030 we performed a field calculation for area with-
in the June, July, and August polygons.
Evaluating disease awareness
The results of the geospatial analysis delineating
the geographic areas at higher risk informed the sec-
ond portion of our study, which evaluated the level
of Chagas disease awareness among physicians
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working in the higher-risk areas; it is through physi-
cians’ diagnosis that disease emergence will be rec-
ognized. In preparation for the survey, we consulted
two medical professionals along with past physician
surveys for procedural and content advice (Tambor
et al., 1993; Bowen et al., 2005). The survey con-
sisted of a vignette depicting a patient with typical
symptoms of Chagas disease and general back-
ground questions on the canvassed physicians. The
underlying purpose of the survey (to evaluate
Chagas awareness) was not disclosed to the partici-
pants. Three versions of the vignette were used, and
all were identical in every way except for the eth-
nicity of the patient (African American, Caucasian,
and Hispanic). The online survey was tested using a
pilot study with three physician participants, and an
invitation to participate in the final survey was sent
to 300 physicians. We recruited physician partici-
pants using information gathered from online
searches of hospitals within the following
cities/county, all of which have a population over
50,000 and are within the potential range of the
vector: Corpus Christi, Texas; Modesto, California;
Rutherford County, Tennessee; Jackson, Missis-
sippi; and Santa Fe, New Mexico. These areas were
selected because three of the Chagas disease  cases in
the United States were discovered in or around
them, and/or they represent locations within the
area at higher risk for disease transmission. 
We sent 20 surveys of each ethnicity to physicians
in the five participating cities, which totaled 60
physician surveys per city. Each physician was asked
to read the vignette and then make an initial diag-
nosis by ranking ten of eleven diseases/health prob-
lems listed according to their likelihood for diagno-
sis, along with the lab studies or tests they would
order to further evaluate the patient. The physi-
cians’ personal information, such as: ethnicity and
gender; commonly read journals; specialty and geo-
graphic location of the practice; patient base; and
when/where they received their professional educa-
tion was also requested. Follow-up reminders were
sent to those physicians who did not initially com-
plete the survey.
Statistical analyses were used to determine if a sig-
nificant difference exists in diagnosis depending on
the ethnicity of the patient described in the vignette.
A one-tailed Fisher’s exact test using the VassarStats
website was found to be the best test for this analy-
sis (Lowry, 2007); in order to perform the preferred
chi-square test, 80% of the cell values must be
greater than or equal to 5 (Marks, 1989), and our
data did not meet this requirement.
Under the null hypothesis, the proportion of
physicians that considered Chagas disease based
upon a specific patient ethnicity is equal to the pro-
portion of physicians who considered Chagas dis-
ease based upon a patient of another ethnicity.
Under the alternative hypothesis, the proportion of
physicians ranking Chagas disease in differential
diagnosis is not identical with respect to ethnicity.
Other survey information regarding lab studies/tests
and the physicians’ background information provid-
ed in the survey was analyzed qualitatively.
Results
Areas of increased risk of Chagas disease transmis-
sion
The overlay analysis of the gridded nightlights
layer delineating populated areas within the United
States with triatomine samples illustrates the vec-
tor’s proximity to these areas (Fig. 2). Samples have
been collected in or near heavily populated areas of
southern California, northern Utah, Missouri, cen-
tral Tennessee, northern Georgia, southern Texas,
and Florida. Despite the sizeable triatomine range
depicted in Figure 2, only certain areas within the
United States are considered at higher risk for
Chagas disease transmission based upon warmer
temperatures, which increase triatomine activity
and increase the likelihood of contact with humans. 
The areas predicted to be at increased risk under
current and predicted temperature conditions are
shown in Figure 3. In Figure 3A, the June 2000
range at higher risk covers a small portion of the
southwestern United States and much of the south-
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central and southeastern portion of the country. A
small area in southern California, Nevada, and the
southern half of Arizona are at increased risk, along
with most of Texas (except the extreme western por-
tion and the panhandle), and the southern half of
Oklahoma across to the eastern coast of the United
States. By July, the range of higher risk expands into
southern Utah, and also expands to the north in the
Midwest and eastern United States (Fig. 3B). Finally,
the current higher risk range contracts between July
and August primarily in the central United States,
and by August (Fig. 3C) only covers a portion of
Kansas and excludes Missouri and Illinois. The areas
of higher elevation across the southern United States,
including the southern Rocky Mountains and the
southern Appalachians, are excluded from the high-
er risk areas in all months.
The population at increased risk grows consider-
ably between June and July, and decreases some-
what between July and August (Fig. 4). This is
directly tied to the relatively large temperature
increase between the months of June and July, and a
slight temperature decrease into the month of
August. Between July and August, the eastern coast
does not experience as much of a decrease in higher
risk as does the central United States. Consequently,
the larger population found on the eastern coast
may explain why there is only a slight decrease in
affected population for the month of August for the
country as a whole (Fig. 4).
For each of the three months, the area at increased
risk for Chagas disease transmission expands under
the predicted 1°C (1.8°F) temperature increase,
although the expansion varies from month to
month. For the month of June, the higher risk
region expands in area by 23% between 2000 and
2030; this percentage increase is noticeably higher
than the increase for July and August, which is 15%
Fig. 2. Triatomine samples and autochthonous Chagas disease cases and their proximity to populated areas in the United
States. Data sources: Usinger, 1944; Woody and Woody, 1955; Anonymous, 1956; Sjogren and Ryckman, 1966; Lent and
Wygodzinsky, 1979; Betz et al., 1984; Ryckman, 1984; Schiffler et al., 1984; Navin et al., 1985; Ochs et al., 1996; Bradley et
al., 2000; Herwaldt et al., 2000; Yabsley and Noblet, 2002; ESRI, 2005; NOAA-NGDC, 2007.
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and 16%, respectively. As is evident from Figure 3,
the range at higher risk due to a temperature-
induced increase in triatomine activity will expand
northward in the Midwest and north along the
Atlantic coast, placing a considerably larger popula-
tion in the higher risk range for disease transmis-
sion. The area affected by increasing temperatures
between 2000 and 2030 illustrates the impact of
predicted climate change on vector-borne disease
transmission and reveals a need for ongoing studies
to prevent or control disease emergence.  
Spatial pattern validation
Given that this study evaluated the potential for
Chagas disease emergence in the United States, a
database of cases does not exist for model validation
and so we utilized two other forms of model valida-
Fig. 3. Areas of increased risk of Chagas disease transmission. Data sources: ESRI, 2005; Spatial Climate Analysis Service, 2006.
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tion in order to evaluate the accuracy and usefulness
of the model (Rykiel, 1996). The first validation
compares our results to the findings from an ecolog-
ical niche model (GARP) and the second validation
compares our results with the location of the six
autochthonous cases of Chagas disease in the United
States. The results of the GARP model, which
focused on the south-central portion of the United
States, depicts the T. gerstaeckeri range as covering
the southwestern portion of Texas, extending into
the panhandle and the southeastern corner of New
Mexico (Beard et al., 2003). The range depicted in
the GARP model overlaps our results through the
southeastern tip of New Mexico and southwestern
Texas; however, the maps differ where the GARP
model’s range extends further north through the
Texas panhandle and southeastern New Mexico.
This difference is likely due to our use of an
increased activity threshold for the vector, whereas
the GARP model is based solely upon the vector’s
distribution.
The six autochthonous cases in the United States,
while representing a small sample, serve as the sec-
ond form of validation of our model. A comparison
of case location with the area defined at
increased risk in this study reveals that five of the six
autochthonous cases in the United States occurred
within the area currently delineated as higher risk
for disease transmission. All point data representing
the five diagnosed cases are within the 2000 range
for both July and August except for the case from
Lake Don Pedro, California, which is not depicted
in the defined higher risk range for June, July, or
August. We recognize in this study that the vector is
likely to be present outside of the area that we
define as “higher risk”; however, our goal is to
define areas where the risk of transmission is greater
due to increased vector activity at warmer tempera-
tures.
Physician awareness of Chagas disease in the United
States
Of the 300 physicians canvassed for this study,
there was only a 7% response rate. This lackluster
response limits quantitative analysis; however,
through the use of a contingency table and the
Fisher’s exact test, we were able to establish a meas-
ure of statistical significance based upon the
patient’s race/ethnicity described in the vignette. Of
the 22 physicians who responded to the survey,
eight ranked Chagas disease as a potential diagnosis
and 14 did not. Among those who ranked Chagas
disease, four were based upon the Hispanic vignette,
and four were not. The four that were not based
upon the Hispanic vignette consisted of three for the
Caucasian patient and one for the African American
patient, neither of which were statistically signifi-
cant. Among the 14 physicians not ranking Chagas
disease as a potential diagnosis, one was based upon
the Hispanic patient and 13 were not. The Fisher’s
exact test reveals a P-value of 0.039. This statisti-
cally significant value (α = 0.05) indicates that
physicians practicing within the range at higher risk
for Chagas disease, as defined by the GIS analysis,
are more likely to consider Chagas disease in differ-
ential diagnosis of Hispanic patients than for either
Caucasian or African-American patients.
Qualitative analysis reveals that travel history is a
concern for some physicians. Fourteen percent of
participating physicians requested information on
the patients’ travel history alone, indicating recogni-
tion that travelers can be responsible for the intro-
duction of disease agents. In one case, Chagas dis-
Fig. 4. Population at higher risk for Chagas disease transmis-
sion due to climate change (SEDAC, 2007).
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ease is specifically written next to the statement
indicating the need for travel history, and another
participant states that he or she “must know geog-
raphy or travel history to prioritize infectious eti-
ologies.” These data are valuable to further illus-
trate that Chagas disease is not always considered as
a possible diagnosis in the areas defined to be at
increased risk in the United States. Physician ethnic-
ity or education information did not appear to be a
factor in the survey results. 
Discussion 
Using the frameworks of disease ecology and land-
scape epidemiology with a broad-scale geographical
approach, this study has examined the potential for
Chagas disease to emerge in the United States.
Specifically, areas at higher risk for Chagas disease
emergence were identified based on temperature
conditions using GIS analyses, and within the high
risk range, the survey analysis indicates that a lack of
physician awareness contributes to disease emer-
gence potential. While the sylvatic nature and
delayed defecation exhibited in triatomine species
within the United States indicate a relatively low risk
of Chagas disease transmission, there is clearly the
potential for emergence given evidence of increased
triatomine domesticity (Beard et al., 2003), appro-
priate climate conditions for triatomine activity, and
a general lack of awareness among physicians when
considering Chagas as a potential diagnosis. While
previous research suggests that the northern limit of
the triatomine range in the United States currently
extends beyond 40 degrees north latitude, the study
presented here indicates that the risk of Chagas dis-
ease transmission is highest in the lower latitudes in
the southern portion of the country. 
The results presented here fill an important gap in
our understanding of the emergence and manage-
ment of Chagas disease in the United States. In an
applied sense, our study has identified areas where
we should focus public health resources for vector
control and outbreak prevention. The study has also
shown that there is a need to raise awareness levels
about the disease among health care professionals,
particularly those within the high-risk area.
Limitations of the study are related to differing
opinions about the classification of triatomine
species, selection of the utilized threshold data, and
the use of 2000 census data in predictive mapping.
Due to the broad-scale approach used in this study,
we believe the general argument is sound in spite of
these limitations. Nevertheless, future fine-scale
studies of Chagas disease in the United States should
factor in these limitations as well as additional vari-
ables that pertain to the specific region of study and
the particular triatomine species present.
Ryckman (1984) indicates that the lack of taxo-
nomic information on triatomines has led to con-
flicting scientific conclusions about the species’ dis-
tribution. Threshold data is frequently difficult to
obtain and oftentimes reports vary. Uncertainty may
arise due to the application of the 19°C (67°F) min-
imum threshold to the three species highlighted in
this study when, in fact, the threshold data are
based solely on T. protracta because of the dearth of
information on other species (Sjogren and
Ryckman, 1966). Finally, the gridded population
data are based on the 2000 census, and when con-
sidering the population at risk under warmer tem-
peratures, population growth and the movement of
people is not taken into account. With respect to the
physician survey, a larger response would increase
the power of statistical analyses and allow for more
extensive conclusions to be drawn on the considera-
tion of Chagas disease as a diagnosis. Conducting a
local survey as part of a fine-scale study may
increase the participation rate. Nevertheless, the
results of this study offer a different perspective with
which to investigate broad-scale disease potential,
and also elucidate the need for future research in
order to improve our understanding of the ways in
which environmental conditions and physician
awareness can interact in disease emergence. 
Reports that triatomine contact with domestic
dogs presents an increased risk of Chagas disease
transmission to humans points toward the need for
increased collaboration between epidemiologists,
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entomologists, and veterinarians in future disease
risk predictions (Barr et al., 1995; Bradley et al.,
2000; Beard et al., 2003; Enger et al., 2004;
Crisante et al., 2006). The results presented here
might serve as insight for comprehensive fine-scale
studies of areas that are in the margins of the
defined higher-risk ranges through a GIS model that
utilizes weighted variables acquired from landscape,
ecological, and environmental data. In addition, as
the T. cruzi infected population grows through
international migration and the close proximity of
triatomines to people becomes greater, it is neces-
sary to study the risk of disease transmission within
the high-risk area. Finally, the results of this study
show a clear need to further evaluate Chagas disease
as a potential diagnosis among physicians and
healthcare providers given the important role they
play in the early detection of emerging diseases. 
In order to maintain an able-bodied society, it is
necessary to direct public health resources towards
present health threats as well as emerging diseases
such as Chagas disease. The factors of triatomine
biogeography and Chagas disease awareness char-
acterize the regions at higher risk for Chagas disease
emergence in the United States, and justify a need
for in-depth investigation so as to alleviate the
potential for disease emergence. In order to prevent
or control vector-borne disease epidemics, it is first
necessary to delineate areas at highest risk for trans-
mission, followed by the implementation of a plan
of action that includes educating both the general
population and public health officials about the dis-
ease risk and methods for controlling the vector.   
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